Health care issues in H.R.1, To provide for reconciliation pursuant to title II of H. Con. Res. 14 (Public Law No: 119-21); Issues related to vaccines
Literal federal measure citations: H.R.1, H. Con. Res. 14
Source-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 21, 2025
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- AVENUE SOLUTIONS
- Client
- MERCK & CO. INC.
- Filing UUID
- 8a645246-d852-45f9-ba46-cee76b9b057a
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Value of prescription drugs; Issues related to Medicare Parts B and D; Issues related to Medicare and Medicaid coverage and reimbursement; H.R. 946/S. 1862, ORPHAN Cures Act; Issues related to cyclic peptides; Issues related to Average Sales Price (ASP) and Part B Medicare negotiation; Issues related to Most Favored Nation (MFN) drug pricing proposal; H.R.4299, Protecting Patient Access to Cancer and Complex Therapies Act
Literal federal measure citations: H.R. 946, S. 1862, H.R.4299
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.